Tiny biotechs fear ‘nuclear winter’ from Pelosi drug pricing bill

Tiny biotechs fear ‘nuclear winter’ from Pelosi drug pricing bill

It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill

By NICHOLAS FLORKO

ALEX HOGAN/STAT

Washington hasn’t considered how small biotech companies will fare under Pelosi’s drug pricing bill — but CEOs predict a devastating effect on investment.

READ MORE